3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
7
NIH
2
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Uterine Cervical Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Dysplasia
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Skin Neoplasms
1
Sarcoma, Endometrial Stromal
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Leiomyosarcoma
1
Leiomyoma
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Interventions
Esomeprazole
3
Radiofrequency Ablation
2
Endoscopy, Digestive System
2
rofecoxib
1
YF 476
1
X-Rays
1
Narrow Band Imaging
1
Lansoprazole
1
Endoscopy
1
Diagnostic Imaging
1
Dexlansoprazole
1
Cryosurgery
1
Blood Specimen Collection
1
Biopsy
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Barrett Esophagus
×
Biopsy
×
Clear all
NCT01209013
2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3
Withdrawn